| Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression M Candolfi, JF Curtin, WS Nichols, AKMG Muhammad, GD King, ... Journal of neuro-oncology 85, 133-148, 2007 | 401 | 2007 |
| Release of HMGB1 in response to proapoptotic glioma killing strategies: efficacy and neurotoxicity M Candolfi, K Yagiz, D Foulad, GE Alzadeh, M Tesarfreund, ... Clinical Cancer Research 15 (13), 4401-4414, 2009 | 103 | 2009 |
| A changing paradigm of transcriptional memory propagation through mitosis KC Palozola, J Lerner, KS Zaret Nature reviews Molecular cell biology 20 (1), 55-64, 2019 | 90 | 2019 |
| Chromatin scanning by dynamic binding of pioneer factors KS Zaret, J Lerner, M Iwafuchi-Doi Molecular cell 62 (5), 665-667, 2016 | 67 | 2016 |
| Two-parameter mobility assessments discriminate diverse regulatory factor behaviors in chromatin J Lerner, PA Gomez-Garcia, RL McCarthy, Z Liu, M Lakadamyali, ... Molecular cell 79 (4), 677-688. e6, 2020 | 62 | 2020 |
| Human mutations affect the epigenetic/bookmarking function of HNF1B J Lerner, A Bagattin, F Verdeguer, MP Makinistoglu, S Garbay, T Felix, ... Nucleic acids research 44 (17), 8097-8111, 2016 | 55 | 2016 |
| A novel bicistronic high-capacity gutless adenovirus vector that drives constitutive expression of herpes simplex virus type 1 thymidine kinase and tet-inducible expression of … M Puntel, A Muhammad, M Candolfi, A Salem, K Yagiz, C Farrokhi, ... Journal of virology 84 (12), 6007-6017, 2010 | 42 | 2010 |
| Study of the efficacy, biodistribution, and safety profile of therapeutic gutless adenovirus vectors as a prelude to a phase I clinical trial for glioblastoma AKMG Muhammad, M Puntel, M Candolfi, A Salem, K Yagiz, C Farrokhi, ... Clinical Pharmacology & Therapeutics 88 (2), 204-213, 2010 | 41 | 2010 |
| Low-dose aspirin protective effects are correlated with deregulation of HNF factor expression in the preeclamptic placentas from mice and humans A Ducat, A Vargas, L Doridot, A Bagattin, J Lerner, JL Vilotte, C Buffat, ... Cell Death Discovery 5 (1), 94, 2019 | 17 | 2019 |
| Two-parameter single-molecule analysis for measurement of chromatin mobility J Lerner, PA Gómez-García, RL McCarthy, Z Liu, M Lakadamyali, ... STAR protocols 1 (3), 100223, 2020 | 6 | 2020 |
| Los procesos pedagógicos y sus vicisitudes. Reflexiones y aproximaciones. Texto inédito. Biblioteca Luis Echavarría Villegas J Lerner, A Vargas Universidad EAFIT, Medellín, 2004 | 6 | 2004 |
| Evaluation of proapototic transgenes to use in combination with Flt3L in an immune‐stimulatory gene therapy approach for Glioblastoma multiforme (GBM) M Candolfi, GD King, AKMG Muhammad, M Puntel, KM Kroeger, C Liu, ... The FASEB Journal 22, 1077.13-1077.13, 2008 | 4 | 2008 |
| A LAMP sequencing approach for high-throughput co-detection of SARS-CoV-2 and influenza virus in human saliva R Warneford-Thomson, PP Shah, P Lundgren, J Lerner, J Morgan, ... Elife 11, e69949, 2022 | 2 | 2022 |
| Growth of pancreatic cancers with hemizygous chromosomal 17p loss of MYBBP1A can be preferentially targeted by PARP inhibitors A Hsieh, JR Pitarresi, J Lerner, G Donahue, D Hsiehchen, AK Rustgi, ... Science Advances 6 (49), eabc4517, 2020 | 2 | 2020 |
| Deregulation Debate in the German Electricity Supply Industry J Lerner, C Riechmann Utilities Law Review 9, 33-41, 1998 | 2 | 1998 |
| Distinct Chromatin Scanning Modes Lead to Targeting of Compacted Chromatin by Pioneer Factors FOXA1 and SOX2 J Lerner, A Katznelson, J Zhang, KS Zaret bioRxiv, 2022.12. 22.521655, 2022 | 1 | 2022 |
| Carm1 regulates the speed of C/EBPα-induced transdifferentiation by a cofactor stealing mechanism GT Garcia, E Kowenz-Leutz, TV Tian, A Klonizakis, J Lerner, ... bioRxiv, 2022.10. 03.510647, 2022 | | 2022 |
| COV-ID: A LAMP sequencing approach for high-throughput co-detection of SARS-CoV-2 and influenza virus in human saliva R Warneford-Thomson, PP Shah, P Lundgren, J Lerner, BS Abella, ... medRxiv, 2021.04. 23.21255523, 2021 | | 2021 |
| 43. Enhancement of Oncolytic Properties of Genetically-Engineered Fusogenic Newcastle Disease Virus through Antagonism of Cellular Innate Immune Responses M Candolfi, W Xiong, AG Muhammad, M Puntel, C Liu, KM Kroeger, ... Molecular Therapy 16, 1, 2008 | | 2008 |
| Validation of HSV1-TK plus ganciclovir in combination with the immune-stimulant Flt3L as a powerful therapeutic target for Glioblastoma multiforme in a preclinical syngeneic … M CANDOLFI, G King, A Muhammad, M Puntel, K Kroeger, C Liu, ... Cancer Research 68 (9_Supplement), 2870-2870, 2008 | | 2008 |
